CN111514236A - 一种治疗心肌梗死(塞)的中药组合物 - Google Patents

一种治疗心肌梗死(塞)的中药组合物 Download PDF

Info

Publication number
CN111514236A
CN111514236A CN202010464481.7A CN202010464481A CN111514236A CN 111514236 A CN111514236 A CN 111514236A CN 202010464481 A CN202010464481 A CN 202010464481A CN 111514236 A CN111514236 A CN 111514236A
Authority
CN
China
Prior art keywords
parts
infarction
myocardial infarction
myocardial
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010464481.7A
Other languages
English (en)
Inventor
仲崇允
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202010464481.7A priority Critical patent/CN111514236A/zh
Publication of CN111514236A publication Critical patent/CN111514236A/zh
Priority to CN202110531026.9A priority patent/CN116115705A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11Pteridophyta or Filicophyta (ferns)
    • A61K36/12Filicopsida or Pteridopsida
    • A61K36/126Drynaria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/29Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/41Crassulaceae (Stonecrop family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/483Gleditsia (locust)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488Pueraria (kudzu)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8969Polygonatum (Solomon's seal)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

本发明公开了一种治疗心肌梗死(塞)中药组合物,是由下列重量份的原料药组成:苏合香0.5~1份;猪牙皂1~1.5份;三七粉1.5~3份;前胡4.5~9份;生蒲黄、红景天6~12份;骨碎补、黄精、十大功劳、大血藤、葛根10~20份;蕨麻、广金钱草15~30份。本发明具有治疗效果显著、治疗周期短、无毒副作用等特点。

Description

一种治疗心肌梗死(塞)的中药组合物
技术领域
本发明属于中药技术领域,尤其是涉及一种治疗心肌梗死(塞)的中药组合物。
背景技术
心肌梗塞是冠状动脉闭塞,血流中断,使部分心肌因严重的持久性缺血而发生局部坏死。
急性心肌梗死是冠状动脉急性、持续性缺血缺氧所引起的心肌坏死。临床上多有剧烈而持久的胸骨后疼痛,休息及硝酸酯类药物不能完全缓解,伴有血清心肌酶活性增高及进行性心电图变化,可并发心律失常、休克或心力衰竭,常可危及生命。
中国近年来呈明显上升趋势,每年新发至少50万,现患至少200万。
西医见效快,但是,容易复发,治标不治本。
发明内容
本发明的目的在于改进已有技术的不足而提供一种心肌梗死(塞)的中药组合物,具有治疗效果显著、治疗周期短、无毒副作用等特点。
本病属于中医“真心痛”、“厥心痛”等病的范畴。
厥心痛指邪犯心包或诸脏之邪犯心之支脉所致之心痛。《医学入门》卷五:“厥心痛,因内外邪犯心包络,或他脏邪犯心之支脉。谓之厥者,诸痛皆少阴、厥阴气逆上冲,又痛极则发厥也。新者身既受寒,后又伤冷,郁遏元阳,宜草豆蔻丸、鸡舌香散温散之,或神保丸温利之……”
《难经·第六十难》:“其五脏相干,名厥心痛。”杨玄操注:“诸经络皆属于心,若一经有病,其脉逆行,逆则乘心,乘心则心痛,故曰厥心痛。”
心肌梗死之血脉闭阻,多为痰瘀交阻、痹阻心脉。表现为阴虚热灼肺阴成痰而为阴虚血瘀挟痰浊,或阳虚水气不化,聚而上泛而为阳虚血瘀夹痰浊。治疗心肌梗死应活血化瘀、补气化浊。
基于上述理论,本发明的技术方案是:一种内服用于治疗心肌梗死(塞)的中药,由下列重量份的原料药组成:苏合香0.5~1份;猪牙皂1~1.5份;三七粉1.5~3份;前胡4.5~9份;生蒲黄、红景天6~12份;骨碎补、黄精、十大功劳、大血藤、葛根10~20份;蕨麻、广金钱草15~30份。
在一个优选的实施方案中,所述治疗心肌梗死(塞)的中药组合物由下列重量份的原料药组成:苏合香1份;猪牙皂1.5份;三七粉3份;前胡9份;生蒲黄、红景天12份;骨碎补、黄精、十大功劳、大血藤、葛根20份;蕨麻、广金钱草30份。
其中,苏合香:辛,温。归心、脾经。开窃,辟秽,止痛。苏合香具有显着的抗心肌缺血的效果,显著增加心肌梗塞患者的冠窦血流量,明显使其恢复正常或接近正常,并能明显减慢心率,明显降低心肌耗氧量,减慢心率和动-静脉压差。对于心肌缺血性超微结构改变有明显的保护效果,并能对抗心肌营养性血溶量的降低及去甲肾上腺素所致的主动脉收缩。
骨碎补:苦,温。归肾、肝经。补肾强骨,续伤止痛。骨碎补能增加心肌细胞的搏动频率,使收缩有力,并对心肌细胞有起搏作用。
猪牙皂:辛、咸,温;有小毒。归肺、大肠经。祛痰开窍,散结消肿。注意孕妇及咯血、吐血患者禁用。明显对抗急性心肌缺血,明显减小心肌缺血时心肌梗死范围,且作用时间持久。
红景天:寒;甘;涩。肺经。补气清肺;益智养心;收涩止血;散瘀消肿;止咳,止带。红景天能降低心脏的负荷,改善心脏功能,可增强缺血心脏的泵血功能,加快血流,纠正因缺血引起的心脏血流动力学的紊乱。红景天具有益气、活血、化淤的功效,能清除血管垃圾,提高血红蛋白数量,提高血氧含量,减少心肌梗塞的面积,对心肌缺氧具有保护作用,并能修复受损的心肌细胞,恢复心脏活力。
生蒲黄:甘,平。归肝、心包经。止血,化瘀,通淋。蒲黄能降低冠心病人总胆固醇、升高高密度脂蛋白胆固醇、降低血小板粘附和聚集性,防止粥样动脉硬化。同时对血管内皮细胞有保护作用,并能抑制粥样硬化斑块形成,扩张心肌内小动脉,改善心肌营养,使冠状动脉血流量增加、阻力下降,明显减小心肌梗死范围。
黄精:甘,平。归脾、肺、肾经。补气养阴,健脾,润肺,益肾。黄精能明显降低甘油三酯、β-脂蛋白和血胆固醇,可减轻主动脉壁内膜上的斑块及冠状动脉粥样硬化程度。极其明显增加冠状动脉血流量(与氨茶碱0.75mg/kg相当),对抗急性心肌缺血。能使其耐缺氧能力明显提高,促进T波异常提前恢复。
蕨麻:甘;苦;寒。归脾;胃经。补气血;健脾胃;生津止渴。蕨麻能显著降低缺血所致心电图J点的抬高, 减轻心肌超微结构损伤程度、减少缺血损伤心肌酶的释放, 明显减少心肌组织缺血面积,缺血所致肌纤维紊乱、线粒体膜和嵴融合、间质水肿等超微结构损伤均显著减轻,可显著降低缺血心肌组织蛋白表达。对缺血心率无明显影响。服用后,可显著提高血清中SOD活力,减少MDA的产生,并降低NO含量,升高NOS水平。提高机体清除自由基能力,阻断心肌细胞凋亡。
十大功劳: 苦,寒。归肝;胃;肺;大肠经。根、茎有清热解毒、止咳化痰之功效。十大功劳改善更死后衰竭心室功能,使梗死范围减少,促使心肌功能恢复,延长心脏存活时间;能抑制血小板聚集;能显著减慢心率,增加心肌收缩力,降低心肌耗氧量,改善心功能。
大血藤:苦、涩,归大肠、肝经。清热解毒,活血,祛风。败毒消痈,活血通络,祛风杀虫。大血藤能使心肌梗塞已抬高的ST段显着下降,改善心肌乳酸代谢紊乱,并缩小心肌梗塞范围。
白花前胡:苦、辛,微寒。归肺经。散风清热,降气化痰。百花前胡能使左心室心肌梗死面积减小,改善高血压伴左心室肥厚所致左心室顺应性损害,改善心脏功能,增加心脏供血。对主动脉有一定的选择性扩血管作用,在增加心冠脉血流量的同时能显着降低血胆甾醇及血压,延缓心率、增强心收缩振幅、降低β/α脂蛋白比例,改善冠状循环。
广金钱草:甘、淡,凉。归肝、肾、膀胱经。清热除湿,利尿通淋。广金钱草总黄酮能明显抑制血栓形成,明显增加脑血流量和冠状动脉血流量,明显增加心肌营养性血流量, 对急性缺血有明显的保护作用。能显著增加耐缺氧能力,较强清除自由基。对常压缺氧耐受力有显著的增加作用,有缓解血管条痉挛的作用。
葛根:甘;辛;平。归经脾;胃;肺;膀胱经。解肌退热;发表透诊;生津止渴;升阳止泻。葛根总黄酮能增加冠状动脉血流量102%-120%,血管阻力下降50%,在心肌缺血时能增加侧枝血流,并减少与心肌耗氧有关的血流动力学参数,对抗急性心肌缺血,明显减小因缺血引起的心肌乳酸产生。
三七:甘、微苦,温。归肝、胃经。散瘀止血,消肿定痛。
三七可以恢复心肌组织SOD活力,从而抑制心肌脂质过氧化,对心肌缺血及再灌注损伤有明显的保护作用,明显缩小心肌梗塞范围。能减慢心率,明显对抗心房纤颤或扑动,非常明显减少室性异搏数,室速及室颤发生和心律失常持续时间。
三七能增强耐缺氧能力,明显降低心肌氧消耗量和氧利用率,具有改善心肌氧代谢作用。
三七增加冠脉流量57.03%,心输出量显着增加,可使冠脉阻力降低,并伴外周总阻力明显下降,同时血压和心率下降。还能对失血性休克代偿期的心功能有明显保护作用。
三七对心脏收缩性有抑制作用,明显的降低肺动脉压和体动脉压作用,并能对抗因脑垂体后叶素所致的血压升高、冠状动脉收缩的作用。
三七总皂甙明显降低血清脂质含量。显着减轻动脉粥样硬化患者主动脉内膜斑块,使内膜病变覆盖面积下降81%。
本发明是由中国传统的中草药制成,根据中医辨证论治及现代医学的若干原则,选用红景天、生蒲黄、骨碎补、生蒲黄活血化瘀;黄精、红景天刺五加补气;猪牙皂、苏合香祛痰浊;黄精、养阴润肺;黄精健脾,以这些成分确定、功效明晰的天然提取物的有序配伍,组合成了治疗心肌梗死(塞)的中药组合物。
本发明具有明显增加冠状动脉血流量、改善心肌供血、修复损伤心肌细胞、缩小直至消除心肌梗死面积及增强心肌细胞活力等功效,有效治疗心肌梗死(塞)等,安全可靠无明显毒副反应,不伤脾胃,便于患者长期坚持服用,标本兼治,不易复发。
本发明的中药组合物药味数目少,原料易得,工艺简单,成本低,效率高,有利于制药企业进行药品生产、质量控制;产品价格低,易于被患者接受。
本发明的中药组合物治心肌梗死(塞)效果显著,临床实验结果显示,用本药方施治,每日一剂,水煎100-150ml,分成两份,早晚各一份服用,一个月为一个疗程,5-6个疗程治愈率为88%,总有效率为100%。
本发明治疗费用相对低廉,远远低于西医的治疗费用。
本发明还提供了一种由上述治疗 的中药组合物制成的口服制剂,所述口服制 剂包括口服液、片剂、胶囊剂、丸剂等,优选剂型为片剂和胶囊剂,一日一剂,分早晚两次服用。
本发明的中药组合物可以制备成多种剂型。例如,将煎煮后的药液杀菌消毒后装袋,制成口服液;或者将煎煮后的药液进行浓缩,烘干后,加入医学上可接收的辅料,然后制成片剂、胶囊剂、丸剂等。
所述医学上可接收的辅料包括淀粉、糊精、羧甲基纤维素钠、聚乙二醇、磷酸氢钙、海藻酸钠、山梨酸钾等。
以上所述,仅是本发明的较佳实施例而已,并非对本发明作任何形式上的限制,本领域技术人员利用上述揭示的技术内容做出些许简单修改、等同变化或修饰,均落在本发明的保护范围内。

Claims (4)

1.一种治疗心肌梗死(塞)的中药组合物,其特征在于,该中药组合物包括::苏合香0.5~1份;猪牙皂1~1.5份;三七粉1.5~3份;前胡4.5~9份;生蒲黄、红景天6~12份;骨碎补、黄精、十大功劳、大血藤、葛根10~20份;蕨麻、广金钱草15~30份。
2.根据权利要求1所述的一种治疗心肌梗死(塞)的中药组合物,其特征是由下列重量份的原料药组成:苏合香1份;猪牙皂1.5份;三七粉3份;前胡9份;生蒲黄、红景天12份;骨碎补、黄精、十大功劳、大血藤、葛根20份;蕨麻、广金钱草30份。
3.一种治疗心肌梗死(塞)的的口服制剂,其特征是由权利要求1或2中任一项所述的中药组合物制成。
4.根据权利要求3所述的一种治疗心肌梗死(塞)的口服制剂,其特征是包括口服液、片剂、胶囊剂、丸剂,优选胶囊剂和片剂。
CN202010464481.7A 2020-05-28 2020-05-28 一种治疗心肌梗死(塞)的中药组合物 Pending CN111514236A (zh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202010464481.7A CN111514236A (zh) 2020-05-28 2020-05-28 一种治疗心肌梗死(塞)的中药组合物
CN202110531026.9A CN116115705A (zh) 2020-05-28 2021-05-16 一种治疗心肌梗塞的中药组合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010464481.7A CN111514236A (zh) 2020-05-28 2020-05-28 一种治疗心肌梗死(塞)的中药组合物

Publications (1)

Publication Number Publication Date
CN111514236A true CN111514236A (zh) 2020-08-11

Family

ID=71907499

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202010464481.7A Pending CN111514236A (zh) 2020-05-28 2020-05-28 一种治疗心肌梗死(塞)的中药组合物
CN202110531026.9A Pending CN116115705A (zh) 2020-05-28 2021-05-16 一种治疗心肌梗塞的中药组合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202110531026.9A Pending CN116115705A (zh) 2020-05-28 2021-05-16 一种治疗心肌梗塞的中药组合物

Country Status (1)

Country Link
CN (2) CN111514236A (zh)

Also Published As

Publication number Publication date
CN116115705A (zh) 2023-05-16

Similar Documents

Publication Publication Date Title
CN108403882B (zh) 一种治疗冠心病的丹参组合物及其制备方法
CN104069446A (zh) 一种治疗冠心病心绞痛的中药组合物
CN104083438A (zh) 一种缓解高血压的苦瓜中药制剂及制备方法
CN102451340A (zh) 一种治疗痛风的中药足浴方剂
CN100396310C (zh) 一种治疗冠心病的药物
CN111514236A (zh) 一种治疗心肌梗死(塞)的中药组合物
CN113144076A (zh) 一种治疗心肌炎的中药组合物
CN104825956A (zh) 防治中风、康复筋骨关节的药
CN102988747B (zh) 一种三刺降三高的冲剂及其制备方法
CN103845670B (zh) 治疗冠状动脉粥样硬化的冲剂及制备方法
CN102908425A (zh) 一种治疗心脏病及血脂稠的药物及其制备方法
CN105362914A (zh) 一种治疗慢性胃炎的中药组合物
CN100386095C (zh) 一种治疗痛风的药
CN104888004A (zh) 一种治疗冠心病的中草药冲剂及其制备方法
CN103638428A (zh) 一种治疗冠心病的中药组合物
CN104587387A (zh) 一种预防和治疗三高症的组合中药与制备方法
CN114767794B (zh) 一种治疗动脉斑块的中药
CN1109777A (zh) 降脂脱醇食用调料
CN103933368B (zh) 用于治疗产后便秘的药物组合物及其制备方法
CN106138475A (zh) 一种预防糖尿病皮肤病的浴足中药组合物
CN105194105A (zh) 一种治疗心血不足型心律失常的中药
CN111450183A (zh) 一种治疗高血脂、动脉粥样硬化的中药组合物
CN112972581A (zh) 一种参凤静心组合物及其制备方法
CN103948682A (zh) 一种治疗心血不足型心律失常的中药
CN103919996A (zh) 一种治疗动脉硬化的中药

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20200811